<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC6167431/results/search/disease/results.xml">
  <result pre="and topiramate (TPM), initially developed as antiepileptics, are approved for" exact="migraine" post="prophylaxis in adults but not children. The differences in"/>
  <result pre="in their antimigraine mechanism(s) by age remain unclear. Methods: A" exact="migraine" post="model induced by intra-cisternal ( i.c.) capsaicin instillation in"/>
  <result pre="by the irritant capsaicin triggered trigeminovascular system (TGVS) activation mimicking" exact="migraine" post="condition, which were assessed peripherally by the depletion of"/>
  <result pre="results suggest VPA exerted peripheral inhibition in adult, but central" exact="suppression" post="in pediatric migraine-rats. In contrast, TPM involves both central"/>
  <result pre="In contrast, TPM involves both central and peripheral inhibition of" exact="migraine" post="with an optimal therapeutic window in both ages. These"/>
  <result pre="anti-migraine drugs in the future. valproic acid topiramate age difference" exact="migraine" post="CGRP Funding National Taiwan University Hospital 10.13039/501100005762 NTUH 101-M1999"/>
  <result pre="table-count: equation-count: ref-count: page-count: word-count: Introduction As compared with adult" exact="migraine" post="(12–17%) ( Stewart et al., 1994; Wang, 2003), pediatric"/>
  <result pre="migraine (12–17%) ( Stewart et al., 1994; Wang, 2003), pediatric" exact="migraine" post="is characterized by more bilateral involvement, shorter duration, less"/>
  <result pre="processing and cerebrovascular regulation, also plays a pivotal role in" exact="migraine" post="pathophysiology ( Lance et al., 1983). Activation of trigeminal"/>
  <result pre="antimigraine drugs ( Durham and Russo, 1999). In a rat" exact="migraine" post="model induced by intra-cisternal ( i.c.) instillation of capsaicin,"/>
  <result pre="Valproic acid (VPA) and topiramate (TPM), both clinically effective in" exact="migraine" post="prophylaxis were used to validate this animal model. Both"/>
  <result pre="their neuronal stabilizing effects. The hypothesis of cortical hyperexcitability in" exact="migraine" post="pathogenesis has led to a great number of large,"/>
  <result pre="why only a few AEDs have a good efficacy in" exact="migraine" post="prophylaxis. To stabilize the hyperexcitability in the cortex may"/>
  <result pre="be the only mechanism for those effective epileptic drugs in" exact="migraine" post="prophylaxis. The stabilization of TGVS activity, in terms of"/>
  <result pre="are approved by the Food and Drug Administration (FDA) for" exact="migraine" post="prevention in adults and recently TPM was approved in"/>
  <result pre="migraine, but not VPA. However, their off-label use for pediatric" exact="migraine" post="is a common practice. VPA is a GABA transaminase"/>
  <result pre="sinus-evoked firing of TCC neurons in a cat model of" exact="migraine" post="( Storer and Goadsby, 2004), attenuated neurogenic dural vasodilation"/>
  <result pre="of these two drugs on the same animal model of" exact="migraine" post="induced by i.c. capsaicin instillation ( Fan et al.,"/>
  <result pre="access to food and water. Intra-Cisternal Instillation of Capsaicin The" exact="migraine" post="model induced by i.c. instillation of capsaicin is similar"/>
  <result pre="mainly peripheral inhibition of TGVS in adult rats, whereas central" exact="suppression" post="of TCC in pediatrics. VPA at high dose, 100"/>
  <result pre="30 mg/kg, in both central and peripheral responsiveness in this" exact="migraine" post="model. TPM Reduced c-Fos-ir TCC Neurons in Both Age"/>
  <result pre="drugs, are effective in suppressing central (TCC) or/and peripheral (TGVS)" exact="migraine" post="responses induced by capsaicin in both adult and pediatric"/>
  <result pre="inhibition of the TGVS in adults. For TPM, the central" exact="suppression" post="of c-Fos was significantly effective at higher dose (≥30"/>
  <result pre="dose. Interestingly, low-dose TPM is better than high-dose for peripheral" exact="suppression" post="in adult TG and pediatric dura while high-dose TPM"/>
  <result pre="and pediatric dura while high-dose TPM is better in central" exact="suppression" post="at the TCC of both age groups. There may"/>
  <result pre="Migraine Intravenous VPA is clinically effective for abortive therapy of" exact="migraine" post="headaches in adults and children ( Kinze et al.,"/>
  <result pre="et al., 2005). It has been studied and used for" exact="migraine" post="prevention with success ( Linde et al., 2013). VPA"/>
  <result pre="sodium/calcium neuronal channels that inhibit the excitatory process seen in" exact="migraine" post="headaches ( Cutrer et al., 1997). In the same"/>
  <result pre="headaches ( Cutrer et al., 1997). In the same capsaicin-induced" exact="migraine" post="model in adult guinea pigs, VPA suppressed the elevated"/>
  <result pre="includes TNC and upper cervical spinal cord, and the central" exact="suppression" post="by VPA in adult rats is not significant. Different"/>
  <result pre="cervical spinal cord) toward the VPA treatment in i.c. capsaicin-induced" exact="migraine" post="model. As for the age-dependent differences, a better central"/>
  <result pre="TNC neuronal activation via GABA A receptors, whether VPA treats" exact="migraine" post="is mediated by CGRP remains unclear. VPA treatments had"/>
  <result pre="ganglia (DRG) and improve the generalized hyperalgesia resulting from induced" exact="endometriosis" post="( Zhao et al., 2011). This study with capsaicin-induced"/>
  <result pre="endometriosis ( Zhao et al., 2011). This study with capsaicin-induced" exact="migraine" post="model first provides direct evidence that VPA inhibited CGRP"/>
  <result pre="crucial in regulating CGRP expression and release in relation to" exact="migraine" post="pathogenesis ( Thalakoti et al., 2007). Hayasaki et al."/>
  <result pre="It warrants further study to clarify the mechanism of central" exact="suppression" post="by TPM in migraine. In human, it was reported"/>
  <result pre="at low doses of TPM in both peripheral effects, the" exact="suppression" post="of TG CGRP and the rescue of dural CGRP"/>
  <result pre="These results suggest an optimal dose window of TPM for" exact="migraine" post="therapy, namely 30 mg/kg in this study, which is"/>
  <result pre="both VPA and TPM are effective in central or/and peripheral" exact="suppression" post="of capsaicin activation in both adult and pediatric rats."/>
  <result pre="These results validate that this capsaicin-induced animal model can mimic" exact="migraine" post="clinically. The antimigraine responsiveness to VPA and TPM are"/>
  <result pre="different in both pediatric and adult animals. VPA involved central" exact="suppression" post="of TCC in the pediatric rat, in contrast to"/>
  <result pre="their anti-migraine effect in pediatric and adult rat model of" exact="migraine" post="induced by i.c. instillation of capsaicin, via central and"/>
  <result pre="of sexual difference, with association with age-difference, in responsiveness toward" exact="migraine" post="therapy. Author Contributions PH and P-CF designed and conducted"/>
  <result pre="Abu-Arefeh I. Russell G. ( 1994). Prevalence of headache and" exact="migraine" post="in schoolchildren. BMJ 309 765– 769. 10.1136/bmj.309.6957.765 7950559 Akerman"/>
  <result pre="inhibits cortical spreading depression in rat and cat: impact in" exact="migraine" post="aura. Neuroreport 16 1383– 1387. 16056144 Akerman S. Goadsby"/>
  <result pre="Mahfelati F. ( 2005). Sodium valproate versus propranolol in paediatric" exact="migraine" post="prophylaxis. Eur. J. Paediatr. Neurol. 9 333– 338. 10.1016/j.ejpn.2005.05.004"/>
  <result pre="Damigos D. Mavreas V. ( 2009). Anticonvulsant drugs for pediatric" exact="migraine" post="prevention: an evidence-based review. Eur. J. Pain 13 893–"/>
  <result pre="D. W. Schmitt J. et al. ( 2004). Topiramate for" exact="migraine" post="prevention: a randomized controlled trial. JAMA 291 965– 973."/>
  <result pre="Moskowitz M. A. ( 1997). Possible mechanisms of valproate in" exact="migraine" post="prophylaxis. Cephalalgia 17 93– 100. 10.1046/j.1468-2982.1997.1702093.x 9137844 Cutrer F."/>
  <result pre="Different trigemino-vascular responsiveness between adolescent and adult rats in a" exact="migraine" post="model. Cephalalgia 32 979– 990. 10.1177/0333102412455710 22843221 Fan P."/>
  <result pre="M. et al. ( 2001). Valproic acid is effective in" exact="migraine" post="prophylaxis at low serum levels: a prospective open-label study."/>
  <result pre="A. I. Guo Y. ( 2017). Is topiramate effective for" exact="migraine" post="prevention in patients less than 18 years of age?"/>
  <result pre="a combination of the two) for the prophylaxis of episodic" exact="migraine" post="in adults. Cochrane Database Syst. Rev. 6: CD010611. 10.1002/14651858.CD010611"/>
  <result pre="N. et al. ( 2012). Canadian Headache Society guideline for" exact="migraine" post="prophylaxis. Can. J. Neurol. Sci. 39(2 Suppl. 2), S1–"/>
  <result pre="Jacobs D. collab: Migr-001 Study Group. ( 2004). Topiramate in" exact="migraine" post="prevention: results of a large controlled trial. Arch. Neurol."/>
  <result pre="al. ( 2007). Neuron-glia signaling in trigeminal ganglion: implications for" exact="migraine" post="pathology. Headache 47 1008– 1023;discussio n1024– 1005. 17635592 Tsai"/>
  <result pre="1381. 10.1177/0883073808318547 19073842 Wang S. J. ( 2003). Epidemiology of" exact="migraine" post="and other types of headache in Asia. Curr. Neurol."/>
  <result pre="K. D. Lu S. R. ( 2005). Rising prevalence of" exact="migraine" post="in Taiwanese adolescents aged 13-15 years. Cephalalgia 25 433–"/>
  <result pre="ectopic endometrial implants and alleviates generalized hyperalgesia in experimentally induced" exact="endometriosis" post="in rats. Reprod. Sci. 18 28– 45. 10.1177/1933719110381928 20884991"/>
 </snippets>
</snippetsTree>
